HOME >> BIOLOGY >> NEWS
Emory researchers develop model to track the evolution of emerging infectious diseases

With outbreaks of new and frightening infectious diseases such as SARS and monkey pox jumping from the animal kingdom to humans, tracking their spread is vital to public health efforts to contain them. A novel mathematical model developed at Emory University now gives public health leaders another tool to assess the risk of new infectious disease emergence that emphasizes the potentially perilous role of pathogen evolution.

The research led by Emory University biologists Rustom Antia and Roland Regoes, with colleagues from the University of Washington in Seattle and P. & M. Curie University in Paris, appears in the Dec. 11 issue of Nature in their paper "The Role of Evolution in the Emergence of Infectious Disease."

"Tracking the evolution of pathogens is not a new concept, but mutations are usually not taken into account in the models used to assess the emergence of infectious disease. What we have developed is a proposed framework to deal with these mutations that should be kept in mind when developing models for emerging infectious diseases such as monkey pox," says Regoes, lead post-doctoral researcher in Antia's laboratory at Emory.

New pathogens are typically believed to emerge from animal populations when ecological changes increase the pathogens' opportunities to enter the human population and generate subsequent human-to-human transmission.

Current mathematical models used for predicting the spread of emerging infectious diseases in humans operate from the standpoint that diseases stay contained if the basic reproductive number of disease transmissions remains less then one. This means that the average number of secondary infections from persons infected with a disease stays below one. While the disease may still spread to other individuals, the pathogen lines of infection eventually become extinct, preventing the disease from epidemically spreading across the population.

In their Nature paper, the researchers show
'"/>

Contact: Beverly Clark
bclark2@emory.edu
404-712-8780
Emory University Health Sciences Center
10-Dec-2003


Page: 1 2

Related biology news :

1. Emory researchers map structure of anti-cancer molecule
2. Hope Clinic of Emory Vaccine Center receives CDC contract
3. Emory scientists receive NIH MIDAS grant for computer modeling of infectious diseases
4. Emory scientists use enzymes to enhance regeneration of damaged peripheral nerves in mice
5. Emory scientists track down immune sentinel cells with gene gun
6. Emory researchers discover novel mechanism of how anthrax impairs immunity
7. Emory scientists find anti-tumor compounds in magnolia cones
8. Emorys CancerQuest wins top Web award from Scientific American
9. Emory University researchers uncover novel self-assembly of Alzheimers amyloid fibrils
10. Emory Vaccine Research Center study identifies specific gene required for long-term immunity
11. Emory to receive more than $6.5 million to study environmental risk factors for Parkinsons disease

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:8/26/2020)... ... , ... Modality Solutions, a biopharmaceutical cold chain validation engineering firm, ... list is the most prestigious ranking of the nation’s fastest-growing private companies. Modality Solutions ... reported three-year revenue growth of 71 percent. , The Inc. 5000 list represents ...
(Date:8/21/2020)... ... August 20, 2020 , ... NDA ... , a Clinical Operations executive with expertise in clinical trial planning and feasibility, ... as an Expert Consultant. Throughout his career, Mr. Movahhed has helped design and ...
(Date:8/5/2020)... ... ... Regenative Labs has received approval from the Centers for Medicare & Medicaid ... Wharton’s jelly allografts to be assigned a Q code and be approved for application ... jelly allograft product to be recognized as a 361 HCT/P by CMS regulated under ...
Breaking Biology News(10 mins):
(Date:7/1/2020)... Colo. (PRWEB) , ... June ... ... of expert tissue data insights, today announced that the launch of a ... results along with data about the tumor microenvironment (TME). , “Flagship’s TissueInsight ...
(Date:6/28/2020)... ... June 25, 2020 , ... With the COVID-19 pandemic ... drug treatment. In an effort to better understand the cellular responses to COVID-19, ... imaging dataset portraying therapeutic compound effects from over 1,600 approved and referenced molecules ...
(Date:6/28/2020)... ... June 26, 2020 , ... The Security Industry Association ... strong opposition to the recently introduced bicameral Facial Recognition and Biometric Technology ... federal use of nearly all biometric and related image analytics technologies, incorrectly labeling ...
(Date:6/23/2020)... ... June 23, 2020 , ... DeCurtis Corporation, the premier ... that Derek Fournier has been appointed CEO and President. Founder and former CEO, ... , “DeCurtis Corporation has been on an incredible journey for the last ...
Breaking Biology Technology:
Cached News: